Qiagen N.V. balance sheet
At the end of fiscal 2025, Qiagen N.V. had total assets of $6.28bn and shareholders' equity of $3.78bn. It held $839m in cash against $1.65bn of debt: net debt of $815m.
Balance sheet
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 826 | 828 | 221 | 394 | 330 | 393 | 290 | 439 | 658 | 1,159 | 624 | 598 | 881 | 731 | 668 | 664 | 839 |
| Receivables | 194 | 197 | 231 | 251 | 260 | 265 | 274 | 278 | 329 | 352 | 385 | 381 | 362 | 324 | 382 | 349 | 403 |
| Inventory | 131 | 127 | 132 | 135 | 128 | 132 | 137 | 137 | 156 | 163 | 171 | 291 | 328 | 358 | 398 | 279 | 302 |
| Total current assets | 1,333 | 1,365 | 745 | 993 | 921 | 1,149 | 961 | 1,038 | 1,648 | 2,155 | 1,570 | 1,624 | 2,110 | 2,394 | 2,148 | 1,960 | 1,995 |
| Goodwill | 1,337 | 1,352 | 1,734 | 1,760 | 1,856 | 1,888 | 1,876 | 1,926 | 2,013 | 2,109 | 2,141 | 2,364 | 2,351 | 2,353 | 2,476 | 2,425 | 2,701 |
| Total assets | 3,796 | 3,914 | 3,730 | 4,088 | 4,088 | 4,454 | 4,179 | 4,308 | 5,039 | 5,748 | 5,236 | 5,870 | 6,147 | 6,288 | 6,115 | 5,690 | 6,281 |
| Accounts payable | 44 | 48 | 60 | 51 | 51 | 46 | 52 | 51 | 59 | 69 | 85 | 118 | 101 | 99 | 84 | 83 | 73 |
| Deferred revenue (current) | — | — | — | — | — | — | — | — | 49 | 45 | 49 | 57 | 63 | 69 | 66 | 71 | 79 |
| Total current liabilities | 376 | 388 | 452 | 267 | 337 | 432 | 268 | 308 | 325 | 972 | 951 | 572 | 1,517 | 975 | 1,079 | 1,042 | 512 |
| Short-term debt | 50 | 76 | 2 | 1 | 0 | 131 | 0 | — | 0 | 503 | 285 | 43 | 848 | 390 | 588 | 552 | 0 |
| Long-term debt | 870 | 797 | 446 | 846 | 845 | 1,041 | 1,049 | 1,067 | 1,758 | 1,671 | 1,421 | 1,880 | 1,094 | 1,472 | 922 | 840 | 1,654 |
| Total debt | 920 | 873 | 590 | 847 | 845 | 1,172 | 1,049 | 1,067 | 1,758 | 2,174 | 1,706 | 1,923 | 1,942 | 1,861 | 1,510 | 1,392 | 1,654 |
| Shareholders' equity | 2,291 | 2,476 | 2,548 | 2,715 | 2,714 | 2,650 | 2,566 | 2,607 | 2,541 | 2,635 | 2,537 | 2,798 | 3,097 | 3,467 | 3,808 | 3,567 | 3,778 |
| Net debt (negative = net cash) | 94 | 45 | 369 | 453 | 515 | 779 | 759 | 628 | 1,101 | 1,015 | 1,083 | 1,325 | 1,061 | 1,131 | 842 | 728 | 815 |
| Shares outstanding | 232m | 233m | 234m | 236m | — | — | — | — | — | — | — | — | — | — | — | — | — |
Compare with peers
- Bio-rad Laboratories, Inc. balance sheet
- Fortrea Holdings Inc. balance sheet
- Medpace Holdings, Inc. balance sheet
- Bruker Corp balance sheet
- Sotera Health Co balance sheet
Head to head: BIO vs QGENFTRE vs QGENMEDP vs QGEN
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies